Montreal Toulouse Test With Eye Tracking in Intensive Care Unit to Evaluate Comprehension

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Tours

Tours, 37000, France

About this study

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

French speaker, RASS (Richmond Agitation-sedation scale) between -1 and +1, agree for participation

Exclusion criteria

neurovisual disorders

Treatment and study plan

Montreal-Toulouse Test adapted in eye tracking

Other

participant pass an eye tracking test to evaluate comprehension

Primary outcomes

Establish eye tracking standards for the test

Time frame: during hospitalization in intensive care

fixation time measurement in the defined area of interest

Sponsors and collaborators

Lead sponsor

University Hospital, Tours

Other

Registry information

Official study title

Montreal Toulouse 86 Test Modified to be Used With Eye Tracking: Test Automation and Eye Course in Healthy Volunteers and Intensive Care Patients

Acronym: MEXICO

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Oct 14, 2021
Registry last updated: Oct 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed